BRCA mutation carriers' perception about benefits and risks associated with combined hormonal contraceptives use

G Grandi, F Monari, V Boggio Sola… - … European Journal of …, 2022 - Taylor & Francis
Objective To evaluate the actual perceptions about combined hormonal contraceptives
(CHCs) use in BRCA mutation carriers in comparison to women from the general population …

Prescribing for pregnancy: managing chronic headache and migraine

C Ovadia - Drug and Therapeutics Bulletin, 2021 - dtb.bmj.com
Globally, headache disorders are an important cause of disability in adults. As many types of
headache (eg, migraine, tension-type and medication-overuse) are more common in women …

Contraception hormonale et risque vasculaire. RPC Contraception CNGOF

G Plu-Bureau, E Sabbagh, J Hugon-Rodin - … Obstétrique Fertilité & …, 2018 - Elsevier
Résumé Les événements vasculaires veineux ou artériels constituent le principal effet
délétère de l'utilisation des contraceptions hormonales combinées (CHC). Même si leur …

[HTML][HTML] Perspective chapter: modern birth control methods

R Al Kindi, A Al Salmani, R Al Hadhrami… - Studies in Family …, 2022 - intechopen.com
This chapter focuses on various modern birth control methods, including combined oral
contraceptives, progestogen-only pills, progestogen-only injectables, progestogen-only …

The use of progestogen-only pill in migraine patients

G Allais, G Chiarle, F Bergandi… - Expert review of …, 2016 - Taylor & Francis
Migraine is a debilitating neurovascular disorder which is estimated to affect 18% of women
and 6% of men. Two main forms of this neurological disorder must be considered: Migraine …

[HTML][HTML] Migraine and Hormonal Contraception in Gynecological Outpatient Care—Cross-Sectional Study among Practicing Gynecologists in Germany

MP Fitzek, E Storch, LH Overeem, P Kull… - Journal of Clinical …, 2023 - mdpi.com
Hormonal contraception (HC) can influence the migraine burden and should be considered
in the comprehensive management of women with migraine. In this study, we aim to …

[HTML][HTML] Metabolic effects of combined hormonal contraception and a risk for thrombotic events

IV Kuznetsova - Obstetrics and Gynecology, 2016 - en.aig-journal.ru
Objective. To make a systematic review of the data available in the literature on the effect of
combined oral contraceptives with different progestogenic components on the risk of venous …

[HTML][HTML] Topiramate for migraine prevention in fertile women: Reproductive counseling is warranted

M Viana, E Terreno, PJ Goadsby, RE Nappi - Cephalalgia, 2014 - journals.sagepub.com
A 21-year-old woman with migraine without aura was seen in a headache center in Northern
Italy. She had been taking low-dose (levonorgestrel (LNG) 0.1 mg and ethinyl estradiol (EE) …

[HTML][HTML] Прогестеронсодержащие контрацептивы: место в практической гинекологии (в помощь практикующему врачу)

ЮЭ Доброхотова, ЕИ Боровкова, СА Залесская - Гинекология, 2018 - cyberleninka.ru
Прогестеронсодержащие контрацептивы не оказывают существенного влияния на
обменные процессы и могут назначаться пациенткам с системными (сахарный диабет …

Migraine et contraception

H Cappy, C Lucas, S Catteau-Jonard… - Gynécologie Obstétrique & …, 2015 - Elsevier
Migraine is a common pathology in women. Migraine disease is well defined by the
International Headache Society and has to be distinguished from others types of headaches …